Novo Nordisk shares slide as investors question growth and pipeline
Danish group targets more blockbuster drugs as semaglutide patents near expiry
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.businesslive.co.za — the content belongs to Business Day.